Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AMRX - Akermes settles Vivitrol patent challenge with Amneal; shares ahead 3%

AMRX - Akermes settles Vivitrol patent challenge with Amneal; shares ahead 3%

Amneal Pharmaceuticals Inc. Class A
  • Alkermes plc (ALKS +2.9%) inks an agreement with Amneal Pharmaceuticals LLC (AMRX +1.6%) settling the latter's challenge to a U.S. patent covering opioid/alcohol dependence med VIVITROL (naltrexone for extended-release injectable suspension) that expires in 2029.
  • More news on: Alkermes plc, Amneal Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Amneal Pharmaceuticals Inc. Class A
Stock Symbol: AMRX
Market: NASDAQ
Website: amneal.com
Menu
AMRX AMRX Quote AMRX Short AMRX News AMRX Articles AMRX Message Board
Get AMRX Alerts

News, Short Squeeze, Breakout and More Instantly...